Performance of Clinical and Biochemical Parameters in Identifying Renal Histopathology and Predictors of One-Year Renal Outcome in Lupus Nephritis-A Single Centre Study from IndiaDIAGNOSTICSIF3.32022-12-143OAAI
Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center studyRHEUMATOLOGY INTERNATIONALIF2.92018-02-1522PREAI
Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic SclerosisJOURNAL OF RHEUMATOLOGYIF3.42017-04-0126OAAI
INFLUENCE OF HLA-DRB1 & DQB1 ALLELES ON SUSCEPTIBILITY, CLINICAL MANIFESTATIONS AND AUTOANTIBODY REPERTOIRE OF SYSTEMIC LUPUS ERYTHEMATOSUS IN SOUTH INDIAN TAMILSANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
HYPOKALEMIC PARALYSIS IN PRIMARY SJOGREN SYNDROME: IS IT A DISTINCT CLINICAL SUBSET WHICH REQUIRES LIFELONG POTASSIUM SUPPLEMENTATION RATHER THAN IMMUNOSUPPRESSANTS?ANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-010PREAI
The Spectrum of Anti-Chromatin/Nucleosome Autoantibodies: Independent and Interdependent Biomarkers of DiseaseJOURNAL OF IMMUNOLOGY RESEARCHIF3.62014-01-0125OAAI
Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?RHEUMATOLOGY INTERNATIONALIF2.92013-03-314PREAI